Noble News - September

Fall is here, and we’re excited about the possibilities ahead. ??

From new partnerships, to supporting the life sciences community, we're committed to pushing the boundaries of innovation this year. Gear up for an incredibly productive season ahead.

• Study Director, Janet Olugbodi, Ph.D., MSc., will present at the 75th Toxicology Roundtable in Black Hawk, CO., on Monday, September 30th. Her presentation, titled "Ensuring Quality & Efficiency in Preclinical Studies," will focus on key strategies for optimizing study design, execution, and data interpretation, while also addressing regulatory compliance. Janet’s expertise is sure to offer valuable insights that will improve the overall quality of preclinical studies.?

• Cell Therapy Manufacturers! ?? Enhance the quality and safety of your cell and gene therapy products with cutting-edge genotoxicity assays. Our advanced analysis ensures genome stability, DNA integrity, and transgene copy number variation, helping you meet regulatory requirements. Learn more.?

Noble team members attended the 10th Annual BioHealth Capital Region Forum on September 17-18, 2024, at US Pharmacopeia. The event gathered leaders from government, academia, and the biotech industry to discuss the current state of the industry, and to drive growth in the biopharma sector. In attendance was Virginia's Governor Glenn Youngkin, who was honored with the 2024 Biotechnology Innovation Organization Governor of the Year Award.

The event was filled with a lineup of engaging speakers, including Albine Martin with Accelevir, who spoke on the Entrepreneurs in Residence Supporting the BHCR Ecosystem panel. The team appreciated the chance to network with attendees and gained valuable insights and connections.

2024 Crab Trap Pitch Competition Recap

A key highlight of the BioHealth Capital Region Week, is the Crab Trap Competition, held on day 2 of the Conference and featured six innovative startups pitching their groundbreaking solutions to a panel of expert judges.?

Congratulations to the winner,?Linshom Medical, who received a cash prize of $10k from Wilson Sonsini.?

Along with the top prize this year, the judges announced, Cerillo, a company specializing in cutting-edge solutions for microbial research, as the winner of the CRO Services Prize from Noble Life Sciences and Accelevir. In partnership, the company awarded the winner $10K in CRO preclinical services.

A big round of applause for both winners whose presentations were truly inspiring. Their innovative solutions showcased the potential to make significant impacts in the biohealth industry. We’re excited to see how their groundbreaking ideas will advance patient care and drive progress in the field.?

?

Pitch Competition Finalists Included:

• Linshom Medical (Baltimore, MD) - Grand Prize Winner?
• Cerillo (Charlottesville, VA) - CRO Services Prize Winner
• Immobazyme (Stellenbosch, Western Cape, South Africa)
• Liquet Medical (Glen Allen, VA)
• Optosurgical (Columbia, MD)
• Plakous Therapeutics (Winston-Salem, NC)

Spotlight on Dr. Yongping Chen: A Leader in Preclinical Research

Meet Dr. Yongping Chen, an expert in preclinical research with a specialization in in vivo pharmacology, particularly in cancer and autoimmune-inflammatory diseases.

Learn more about Dr. Chen’s background and expertise in his employee spotlight.

How a Preclinical CRO Can Help You Get the Most Out of Your GLP Toxicology Studies?

Maximize the value and get the most out of your GLP toxicology studies!

This article dives into how expert guidance and streamlined processes can enhance your research and fast-track your journey to clinical trials. These insights could be a game-changer in your development process.?Click to read the article.